Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://www.mobihealthnews.com/news/health-data-analytics-startup-komodo-healths-220m-series-e-propels-it-33b-valuation
Some money floating about
BeContrarian - excellent post, thank you. All of us who have been involved here for a while know CF is totally committed to maximising shareholder value and returns. He has demonstrated this repeatedly to date by his words and actions. He has all the skills and experience to know the optimal way to spin-out the non core assets in whichever ways are going to be the most successful for both the core and new businesses, which will maximise investor returns. I too am anticipating continued gains in both short and longer term.
Most LTH’s (myself included) will know that CF won’t just spin off dead rubber. These will be exciting, viable businesses in their own right, packaged properly and ready for market. As CEO, I trust CF to make sure these spin offs are properly handled and run.
No, it won’t happen overnight, I suspect very few LTHs expect it to, but calling one another clowns creates conflict and bad faith in what is a very harmonious and constructive BB.
If you’re looking for a quick buck, you will probably find it here. But life changing money will be the reward for those that see all the spin offs through to fruition.
You pays your money you takes your choice.
Good post Hart - it’s l a judgement call whether to run with the Newco shares or sell as soon as possible
Not if anyone is expecting big returns on day 1 of a spin off, no. Partly because it’s highly likely there will be a lock in period but also because the real return will hopefully come down the line as the spin off increases its market cap, but which we all know isn’t guaranteed. Spin offs shouldn’t involve a placing/dilution by ORPH itself though and CF has categorically said that none will be undertaken.
Examples of EKF spin offs are perfect: Renalytix spun off end 2018 went from £1.20 in Nov 2018 to more than £3.20 in April 2019 (rough prices/dates) then was over £10 last month. Trellus Health spun out in November last year with plan to ipo Q1 2021 but still hasn’t (and still isn’t guaranteed to do so), so EKF shareholders who received Trellus shares at present hold effectively zero value in those as they aren’t yet listed - and when they do become listed there is a 12 month lock in. So it’s a fantastic thing to have these assets being returned to shareholders, but good to understand how it works.
Fully agree Hart - it’s going to be extra for us all but not as easy and lucrative as some Clowns think
Ricky you are correct, all of those things are needed for an ipo and they aren’t simple or cheap, but a new company isn’t suddenly being created out of nothing, it is an independent corporate entity with its own management team and ORPH/ partners have incubated it as a non core asset. They will only spin it off at a point when the public markets would see them as a viable proposition, a placing (ipo - initial public offering, misnomer in that often it’s only open to institutions) to provide them with cash that is required to set them on the road to greater progress and profitability is the point of this instead of relying on the financial support as previously provided by the original owners. The point of the spin off is to reward those original owners for the financial risk already invested, not to cost them more. The funds required to pay for brokers, corporate finance etc would come from the placing.
Many don’t think it’s simple. They just understand how it works. You clearly don’t with your 669m nonsense. You have the weekend to atone your sins. Your right Moni. Keeeeep digging
I'm sure you're right, Ricky. And I guess that all these things take time. But, I'm not in any particular hurry, personally.
But, I would hesitate a guess that your man CF knows all about the requirements and might even have some of it covered already. He seems that sort of guy, tbh.
Is not as simple as many seem to think. A lot on here think all that’s needed is a share issue and we all walk away with an extra 30p (or whatever) per share
When in reality a prospectus needs to be written with a management team / premises / strategy / cash flow forecast etc etc - it will need funds to continue its existence and it needs to be convincing to attract investors. All this needs to be taken into consideration to calculate a launch market cap of the new entity